RefLab is a Danish biotech company located in Copenhagen founded in 1991 as a spin-off of Lundbeck and now a member of R-Biopharm group in Germany.

RefLab has proven track record with several big pharma companies together with established scientific collaborations with national and international universities and hospitals.

We offer clinical sample testing for chronic spontanous urticaria and 
preclinical contract research within PK/PD, translational studies assessing potential hypersensitivity and toxicological effects as well as drug metabolism studies in a human ex vivo immune model. RefLab has a pre-existing ethical clearance, no time delays for project start-up.

Applications for RefLab human ex vivo skin-based immune model is:
Pharmacokinetics and pharmacodynamics
Translational studies – from animal to man
Hypersensitivity reactions to pre-clinical drugs
Drug metabolism in human skin
Cytokine profiling and inflammatory responses
Protein detection and assessment of biological activity

RefLab also has an accredited Service Laboratory with extensive expertise in drug allergy and chronic urticaria testing, serving hospitals, clinics, allergy, immunology & dermatology specialists.

Please also find us on Scientist.com: https://app.scientist.com/domain_switcher?redirect=/providers/reflab-aps 

Biotechnology

Clinical Trials

Health Care

Health Diagnostics

RefLab ApS

Henrik Christensen

Maja Michelsen

This department provides strategic direction and oversight for the organization.

Executive Leadership

This department oversees production operations and manages commercial activities to optimize service delivery.

RefLab ApS

Org chart

Teams

Executive Leadership

Production and Commercial Services

Offices

RefLab ApS

Org chart

Teams

Executive Leadership

Production and Commercial Services

Offices

Related companies